End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.7 SEK | 0.00% | +4.59% | +14.00% |
Feb. 22 | ODI Pharma AB Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 | CI |
2023 | ODI Pharma Sells CBD Skincare Brand for SEK3 Million | MT |
Business Summary
Number of employees: 1
Sales per Business
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceuticals Cannabis and Cosmetic Products
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -55.44% |
Sales per region
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Sweden
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -55.44% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Derek Simmross
FOU | Founder | 56 | 17-12-31 |
Markus Fritzsche
CTO | Chief Tech/Sci/R&D Officer | - | - |
Karina Kilinski
BRD | Director/Board Member | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Derek Simmross
FOU | Founder | 56 | 17-12-31 |
Founder | 44 | 17-12-31 | |
Karina Kilinski
BRD | Director/Board Member | - | - |
Gösta Lidén
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 15,220,000 | 15,067,800 ( 99.00 %) | 0 | 99.00 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+14.00% | 7.91M | |
+25.76% | 661B | |
+26.74% | 566B | |
-6.64% | 352B | |
+20.38% | 332B | |
+2.90% | 283B | |
+13.55% | 231B | |
+4.70% | 200B | |
-9.37% | 195B | |
-5.22% | 145B |
- Stock Market
- Equities
- ODI Stock
- Company ODI Pharma AB